For the quarter ending 2026-03-31, GRDN made $336,595K in revenue. $13,295K in net income. Net profit margin of 3.95%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 336,595 | 397,616 | 377,427 | 344,334 |
| Cost of goods sold | 260,286 | 312,114 | 302,706 | 276,188 |
| Gross profit | 76,309 | 85,502 | 74,721 | 68,146 |
| Selling, general, and administrative expenses | 58,634 | 54,740 | 58,367 | 55,566 |
| Operating income | 17,675 | 30,762 | 16,354 | 12,580 |
| Interest expense | 154 | 163 | 160 | 172 |
| Other expense (income), net | 772 | 500 | 437 | 179 |
| Total other expenses (income) | 618 | 337 | 277 | 7 |
| Income before income taxes | 18,293 | 31,099 | 16,631 | 12,587 |
| Provision for income taxes | 4,749 | 9,834 | 7,038 | 3,760 |
| Net income | 13,544 | 21,265 | 9,593 | 8,827 |
| Less net income attributable to guardian pharmacy, llc prior to the corporate reorganization | - | 0 | 0 | 0 |
| Less net income (gain) attributable to non-controlling interests | 249 | 342 | -225 | -203 |
| Net income attributable to guardian pharmacy services, inc | 13,295 | 20,923 | 9,818 | 9,030 |
| Basic EPS | 0.21 | 0.332 | 0.16 | - |
| Diluted EPS | 0.21 | 0.329 | 0.15 | - |
| Basic Average Shares | 63,321 | 62,991,438 | 62,124,010 | - |
| Diluted Average Shares | 63,692 | 63,544,824 | 63,432,468 | - |